We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Norvasc May Boost Fiscal 2008 Earnings for Mylan Laboratories
Generic Norvasc May Boost Fiscal 2008 Earnings for Mylan Laboratories
April 10, 2007
Driven by strong product performance of its generic business line, Mylan Pharmaceuticals modified financial results for fiscal 2007, increasing its diluted earnings per share guidance range, the company said April 10.